Clinical Research Directory
Browse clinical research sites, groups, and studies.
Twice vs Thrice Weekly Incident Hemodialysis in Elderly Patients
Sponsor: Soonchunhyang University Hospital
Summary
As Korea is becoming a super-aged society, the number of elderly patients with end-stage kidney disease (ESKD) is expected to increase rapidly. Therefore, the burden on Korean society will also increase. Thrice-weekly hemodialysis is standard for renal replacement therapy. However, this regimen has not been validated for elderly ESKD patients with residual renal function. Elderly patients can have multiple comorbidities such as hypertension, diabetes, cardiovascular disease, and impaired physical activity. Frequent hemodialysis could provoke falls, hypotension, and cognitive impairment. Previous reports have suggested the potential benefit of twice-weekly hemodialysis with incremental increases in frequency when residual renal function decreases. In addition, twice-weekly hemodialysis decreases hospitalization rates in frail patients. Therefore, the investigators hypothesized initiating renal replacement therapy with twice-weekly hemodialysis decreases the hopsitalizatoin rates compared with conventional thrice-weekly hemodialysis in elderly ESRD patients with residual renal function. This study is a pragmatic randomized clinical trial, multicenter study. Study subjects are incident ESRD patients (\>= 60 years old, n=428) with residual urine volume ( \> 500 mL/day) and follow up up to 2 years. Twice-weekly hemodialysis could be incremented according to clinical situations such as volume overload, hyperkalemia and uremic symptom. Primary outcome of this study is hospitalization rate during follow-up. Secondary outcomes include dialysis related hospitalization rate, the length of hospital stay, complication of dialysis,mortality rate and assessments of quality of life, frailty, and cost-utility.
Official title: A Pragmatic Randomized Clinical Trial: Twice-weekly vs Thrice-weekly Incident hemoDialysis in Elderly Patients
Key Details
Gender
All
Age Range
60 Years - Any
Study Type
INTERVENTIONAL
Enrollment
428
Start Date
2021-11-23
Completion Date
2026-05-31
Last Updated
2024-05-31
Healthy Volunteers
No
Interventions
Hemodialysis
Number of weekly hemodialysis treatment
Locations (7)
Soonchunhyang University Hospital Bucheon
Bucheon-si, South Korea
Hallym University Medical Center- Chuncheon
Chuncheon, South Korea
Soonchunhyang University Seoul Hospital
Seoul, South Korea
Kangbuk Samsung Medical Center
Seoul, South Korea
Koera University Guro Hospital
Seoul, South Korea
The Catholic University of Korea, Yeouido St. Mary's Hospital
Seoul, South Korea
Yonsei University, Wonju Severance Christian Hospital
Wŏnju, South Korea